MedPath

Catholic University of the Sacred Heart

Catholic University of the Sacred Heart logo
Italy
Ownership
Private
Established
1921-01-01
Employees
-
Market Cap
-
Website
http://www.ucsc.it

Clinical Trials

223

Active:3
Completed:122

Trial Phases

6 Phases

Early Phase 1:3
Phase 1:7
Phase 2:20
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (163 trials with phase data)• Click on a phase to view related trials

Not Applicable
103 (63.2%)
Phase 4
21 (12.9%)
Phase 2
20 (12.3%)
Phase 3
9 (5.5%)
Phase 1
7 (4.3%)
Early Phase 1
3 (1.8%)

Multi-omics Dissection of Gut Microbiome Engraftment During FMT

Not Applicable
Not yet recruiting
Conditions
Recurrent C. Difficile (rCDI)
Ulcerative Colitis (UC)
Metabolic Syndrome (MetS)
First Posted Date
2025-05-28
Last Posted Date
2025-05-28
Lead Sponsor
Catholic University of the Sacred Heart
Target Recruit Count
90
Registration Number
NCT06992453
Locations
🇮🇹

Catholic University of the Sacred Heart, Rome, RM, Italy

Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience

Recruiting
Conditions
Oral Lichen Planus
Oral Carcinoma
Oral Carcinoma in Situ
First Posted Date
2025-04-18
Last Posted Date
2025-04-18
Lead Sponsor
Catholic University of the Sacred Heart
Target Recruit Count
300
Registration Number
NCT06934863
Locations
🇮🇹

Catholic University of the Sacred Heart, Roma, Italy

Feasibility of Innovative Approaches for Personalized Cardiovascular Prevention

Not Applicable
Recruiting
Conditions
Coronary Heart Disease
First Posted Date
2025-04-04
Last Posted Date
2025-04-09
Lead Sponsor
Catholic University of the Sacred Heart
Target Recruit Count
200
Registration Number
NCT06911294
Locations
🇮🇹

Studio Antonaci, Rome, Italy

🇮🇹

Studio Colletti, Rome, Italy

🇮🇹

Studio Maggiori, Rome, Italy

and more 4 locations

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation with Metabolic Syndrome and Insulin-Secreting Cells.

Not Applicable
Not yet recruiting
Conditions
Pancreatic Steatosis
Metabolic Syndrome X
Diabetes Mellitus
First Posted Date
2025-03-25
Last Posted Date
2025-03-25
Lead Sponsor
Catholic University of the Sacred Heart
Target Recruit Count
100
Registration Number
NCT06801769

Restructuring Body Experience in Anorexia Nervosa: Virtual Reality Functionality-Focused Mirror Exposure

Not Applicable
Not yet recruiting
Conditions
Anorexia Nervosa
First Posted Date
2025-02-28
Last Posted Date
2025-02-28
Lead Sponsor
Catholic University of the Sacred Heart
Target Recruit Count
40
Registration Number
NCT06852183
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 45
  • Next

News

Sulthiame Shows Promise in Treating Obstructive Sleep Apnea, Leads ERS Congress 2024 Highlights

A clinical trial presented at ERS Congress 2024 revealed that sulthiame, an epilepsy medication, effectively reduced obstructive sleep apnea symptoms by improving oxygen levels and decreasing breathing interruptions during sleep.

Insights from Failed IPF Trials Highlight Need for Adaptive Designs and Patient-Focused Outcomes

Analysis of recent idiopathic pulmonary fibrosis (IPF) trial failures emphasizes the importance of learning from setbacks to refine future clinical trial designs.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.